Press Releases

  • Antibody synergy targets tough cancers

    Two anti-cancer antibodies have a much stronger effect against pediatric nerve-cell and bone cancers in mice than either one alone, researchers have discovered.

  • Fastest genome sequencing

    A research effort led by Stanford scientists set the first Guinness World Record for the fastest DNA sequencing technique, which was used to sequence a human genome in just 5 hours and 2 minutes.

  • Hematologist Steven Coutre dies

    Steven Coutre was known for his research on chronic lymphocytic leukemia, his humility and his love of traveling and family.

  • 500th heart transplant at Stanford

    Mackenzie Collins was the 500th pediatric patient to undergo a heart transplant at Stanford Medicine.

  • Surgery rates rebounded quickly in pandemic

    After a dramatic drop in nonessential surgery rates early in the pandemic, U.S. hospitals quickly adapted to new safety protocols, and rates returned to normal, Stanford Medicine research shows.

  • Diversity key to cholesterol risk prediction

    A Stanford study shows that using genomes from a diverse pool of people improves the ability to predict an individual’s risk of having high cholesterol.

  • Healthy-aging proponent James Fries dies at 83

    The professor of rheumatology and immunology created an early computer database to follow rheumatology patients. The knowledge he gained from it precipitated his “compression of morbidity” hypothesis.

  • Study: COVID-19 vaccine effective in cancer patients

    The Moderna and Pfizer BioNTech vaccines prevented COVID-19 infection in cancer patients, particularly in those whose treatment concluded more than six months before vaccination, say researchers at Stanford, Harvard and the VA.

  • New immunotherapy targets tumors

    Stanford researchers have developed a synthetic, tumor-targeting molecule that promotes immune activation and tumor regression in laboratory mice after it’s injected into their bloodstreams.

  • COVID-19 nasal spray vaccine

    A potential COVID-19 vaccine, delivered via a squirt up the nose, shows promise in mice.


2023 ISSUE 3

Exploring ways AI is applied to health care